Clinical Trial Update: Pirfenidone, an Antifibrotic and Antiinflammatory Drug [Phase 2]

View source ↗

Summary

Phase 2 trial of pirfenidone, an antifibrotic and anti-inflammatory drug, has completed evaluating its effects in fibrosis and chronic hepatitis C; detailed eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis
• Hepatitis C

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: University of Guadalajara | Conditions: Fibrosis, Hepatitis C Chronic | Phase 2 | Status: COMPLETED